.jpg)
Oslo Børs has revised the composition of the Benchmark Index (OSEBX). The revision resulted in five companies being removed from the index, while four new companies were included.
The Benchmark Index is intended to be an investable index that comprises a representative selection of all the shares listed on Oslo Børs. Since the index is meant to be investable, shares included in the index must be relatively easy to buy and sell in the market at any time.
With effect from 1 June 2013, shares in 5 companies will be removed from the index, while 4 companies will be added to the index. The number of companies included in the index will be 54.
The following companies will be removed from the index:
- Bakkafrost
- Clavis Pharma ASA
- Frontline Ltd
- Salmar ASA
- Songa Offshore SE
The following companies will be included in the index:
- AF Gruppen ASA
- Asetek AS
- Olav Thon Eiendomsselskap ASA
- Polarcus Limited
Se the new composition here: http://www.newsweb.no/newsweb/search.do?messageId=327982
The next review of the Benchmark Index will be in November, with effect from 1 December 2013.
Facts about the Benchmark Index:
OSEBX is a semiannually revised free float adjusted index with changes implemented on 1 December and 1 June respectively. In the period between the review dates the number of shares for each security is fixed with exception of adjustments for corporate actions with priority for existing shareholders. The OSEBX index is adjusted for dividend payments.
The Oslo Børs Benchmark Index was introduced in 2001, and replaced the former total index. Since this time, the number of companies included in the Benchmark Index has varied between 52 and 81.
